Nanomedicine News and Research

RSS

Researchers develop biodegradable microneedle particles to enhance drug delivery

Researchers have developed biodegradable particles with microscopic needles that painlessly puncture the skin to help it absorb drugs delivered through patches or creams.

9 Sep 2026

Advancing intracellular delivery with LumiPore®: A new approach to cell transfection and drug discovery

Discover how LumiPore improves intracellular delivery with gentle, high-efficiency transfection for drug discovery and cell therapy research.

From Trince 8 Sep 2026

New method based on human blood simplifies mRNA drug development

mRNA-based drugs are emerging as the drug of the future for a wide range of diseases, but they are difficult and time-consuming to develop.

1 Sep 2026

Blocking caspase-1 appears to reduce the risk of developing lung tumors

Every year, lung cancer kills more than 100,000 people in the United States. Smoking is the leading risk factor for lung cancer, but other environmental exposures can also contribute to the disease.

14 Aug 2026

UH College of Pharmacy secures funding for three major health studies

University of Houston College of Pharmacy researchers have secured more than $1 million in new funding to support three separate studies targeting sepsis, Alzheimer's disease and related dementias, and depression in patients with sickle cell disease.

11 Aug 2026

Scientists combine imaging and phototherapy in a single tool against glioblastoma

Glioblastoma is the most aggressive form of brain cancer.

6 Aug 2026

Study offers a potential strategy to make nanoparticle-based cancer drugs more effective

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, offering a potential strategy to make nanoparticle-based cancer drugs more effective.

31 Jul 2026

Targeting ZBP1 may overcome cancer immunotherapy resistance

A new Review published in the open-access journal Ferroptosis and Oxidative Stress highlights Z-nucleic acid-binding protein 1 (ZBP1) as an emerging innate immune sensor that converts genomic stress into potent antitumor immunity.

16 Jul 2026

Novel DNA nanoplatform offers hope for chronic gum disease

Millions of people worldwide live with periodontitis, a chronic gum disease that can progressively destroy the tissues and bone supporting the teeth despite conventional treatment.

16 Jul 2026

Targeted nanoparticles destroy tumor cells by triggering cuproptosis

A promising cancer treatment strategy called cuproptosis, which uses copper-dependent cell death to eliminate tumor cells, faces a major challenge: many approaches require adding external copper, potentially increasing toxicity beyond the tumor.

15 Jul 2026

New photoswitchable drugs restore light perception in blind animals

Blinding diseases caused by the degeneration of photoreceptors, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), affect 200 million people worldwide and represent the leading causes of visual impairment and blindness.

15 Jul 2026

Alexandre Detappe wins ERC grant for nanomedicine-based cancer immunotherapy

The ERC (European Research Council) Proof of Concept grant awarded to Alexandre Detappe (Gustave Roussy/Institut Strauss/Université Paris-Saclay/Inserm) will fund the Nano-BITE project, which aims to improve the ability of the immune system to fight solid tumors through nanomedicine.

1 Jul 2026

Sugar-coated nanoparticles extend survival in aggressive glioblastoma mouse model

Researchers at Oregon State University have potentially found a new way to treat the most aggressive form of brain cancer, glioblastoma, whose two-year survival rate is less than 30%.

23 Jun 2026

New DNA tetrahedron nanostructures improve targeted cancer therapy delivery

Conventional cancer treatments, such as chemotherapy, often lack specificity and can damage both cancerous and healthy cells, leading to severe side effects.

10 Jun 2026

CIC biomaGUNE develops pulmonary surfactant nanoparticles to treat lung diseases

The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that lines the alveoli and enables breathing), which are encapsulated in a drug used to treat pulmonary fibrosis.

4 Jun 2026

Virtual AI mouse tests nanomedicine without using living animals

When a tumor manages to nestle itself in the brain of a living being, it has - from the tumor's perspective - done something particularly clever.

28 May 2026

Engineered nanomaterials optimize delivery barriers in cancer immunotherapy

Cancer immunotherapy works by mobilizing the body's own immune system to recognize and destroy malignant cells.

20 May 2026

New mRNA vaccine strategy dramatically amplifies cancer-fighting T cells

Engineers from the University of Houston, MIT and Harvard have developed a new mRNA-based strategy that dramatically amplifies the T-cell response to vaccines - an advance that could lead to far more powerful cancer vaccines and stronger protection against infectious diseases.

19 May 2026

New mRNA adjuvant dramatically boosts T-cell vaccine responses in mice

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines - an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.

13 May 2026

Researchers find new way to deliver drugs directly into cancer cells

National University of Singapore Researchers at the National University of Singapore (NUS) have developed a high-throughput method to identify gold nanoparticles capable of delivering therapies directly to mitochondria (the energy centres inside cancer cells).

13 May 2026